Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Blood Proteome Profiling Identifies Biomarkers Associated with Prognosis in Ischemic Stroke Due to Large Artery Atherosclerosis

NCT06729385 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT06729385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06729385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Blood Proteome Profiling Identifies Biomarkers Associated with Prognosis in Ischemic Stroke Due to Large Artery Atherosclerosis
Lead sponsor
Capital Medical University
Phase
Observational
Overall status
Completed
Start date
December 1, 2024
Completion date
February 20, 2025
Enrollment
80 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

stroke